Walleye Capital LLC Invests $3.78 Million in Addus HomeCare Corporation $ADUS

Key Points

• Walleye Capital LLC acquired a new stake in Addus HomeCare Corporation, investing approximately $3.78 million by purchasing 38,233 shares in the first quarter.
• Analysts have positive outlooks for Addus HomeCare, with a consensus rating of "Buy" and a target price around $138.38.
• Insider transactions revealed that CEO R Dirk Allison sold 25,000 shares for nearly $2.87 million, reducing his ownership by 13.06%.

Walleye Capital LLC bought a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 38,233 shares of the company's stock, valued at approximately $3,781,000. Walleye Capital LLC owned about 0.21% of Addus HomeCare at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. BI Asset Management Fondsmaeglerselskab A S acquired a new position in Addus HomeCare in the first quarter valued at about $41,000. Caitong International Asset Management Co. Ltd grew its position in Addus HomeCare by 368.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock valued at $124,000 after acquiring an additional 987 shares in the last quarter. Bailard Inc. acquired a new position in Addus HomeCare in the 1st quarter valued at about $208,000. EP Wealth Advisors LLC grew its position in Addus HomeCare by 17.8% in the 4th quarter. EP Wealth Advisors LLC now owns 2,202 shares of the company's stock valued at $276,000 after acquiring an additional 332 shares in the last quarter. Finally, Armis Advisers LLC acquired a new position in Addus HomeCare in the 4th quarter valued at about $295,000. Institutional investors and hedge funds own 95.35% of the company's stock.

Wall Street Analyst Weigh In

ADUS has been the subject of several research reports. Barclays lifted their target price on Addus HomeCare from $83.00 to $109.00 and gave the company an "underweight" rating in a research report on Tuesday, August 19th. JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research report on Wednesday, July 16th. Wall Street Zen raised Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. Royal Bank Of Canada lifted their target price on Addus HomeCare from $133.00 to $134.00 and gave the company an "outperform" rating in a research report on Friday, August 22nd. Finally, Macquarie reaffirmed an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Buy" and an average price target of $138.38.

Insider Transactions at Addus HomeCare

In other news, CEO R Dirk Allison sold 25,000 shares of the company's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the transaction, the chief executive officer directly owned 166,461 shares of the company's stock, valued at approximately $19,134,691.95. This represents a 13.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the transaction, the director directly owned 5,067 shares of the company's stock, valued at approximately $582,350.31. This represents a 23.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,310 shares of company stock valued at $3,958,375. 4.50% of the stock is currently owned by corporate insiders.

Addus HomeCare Stock Down 0.1%

ADUS stock traded down $0.15 during mid-day trading on Monday, reaching $115.17. The company had a trading volume of 72,791 shares, compared to its average volume of 190,269. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74. The company has a market capitalization of $2.12 billion, a price-to-earnings ratio of 25.42, a price-to-earnings-growth ratio of 1.75 and a beta of 0.85. The firm has a fifty day simple moving average of $112.10 and a 200 day simple moving average of $106.91. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to analyst estimates of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.Addus HomeCare's revenue for the quarter was up 21.8% compared to the same quarter last year. During the same quarter last year, the company earned $1.35 EPS. Analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.